Keith J. Ebling
Insider
First SEC filing: Oct. 12, 2017 · Latest: Oct. 12, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 19, 2021 | XRAY | G | 31,794 | · | · | 64,199 Indirect | +98.11% | Acquired | (price as of 2026-10-02) |
| Nov. 19, 2021 | XRAY | G | 31,794 | · | · | 14,113 Direct | -69.26% | Disposed | (price as of 2026-10-02) |
| Nov. 12, 2021 | XRAY | G | 32,405 | · | · | 32,405 Indirect | · | Acquired | (price as of 2026-10-02) |
| Nov. 12, 2021 | XRAY | G | 32,405 | · | · | 203 Indirect | -99.38% | Disposed | (price as of 2026-10-02) |
| Nov. 5, 2021 | XRAY | F | 24,682 | $55.81 | $1,377,502 | 45,907 Direct | -34.97% | Disposed | -84.5% (price as of 2026-10-02) |
| Nov. 5, 2021 | XRAY | A | 56,476 | · | · | 70,589 Direct | +400.17% | Acquired | (price as of 2026-10-02) |
| Nov. 3, 2021 | XRAY | G | 32,405 | · | · | 32,608 Indirect | +15963.05% | Acquired | (price as of 2026-10-02) |
| Nov. 3, 2021 | XRAY | G | 32,405 | · | · | 14,113 Direct | -69.66% | Disposed | (price as of 2026-10-02) |
| Oct. 8, 2021 | XRAY | A | 10 | $58.46 | $585 | 5,251 Direct | +0.19% | Acquired | -85.2% (price as of 2026-10-02) |
| Oct. 8, 2021 | XRAY | A | 26 | $60.01 | $1,560 | 46,518 Direct | +0.06% | Acquired | -85.6% (price as of 2026-10-02) |
| July 9, 2021 | XRAY | A | 9 | $62.57 | $563 | 5,241 Direct | +0.17% | Acquired | -86.1% (price as of 2026-10-02) |
| July 9, 2021 | XRAY | A | 24 | $64.18 | $1,540 | 46,492 Direct | +0.05% | Acquired | -86.5% (price as of 2026-10-02) |
| April 9, 2021 | XRAY | A | 8 | $64.17 | $513 | 5,232 Direct | +0.15% | Acquired | -86.5% (price as of 2026-10-02) |
| April 9, 2021 | XRAY | A | 23 | · | · | 46,468 Direct | +0.05% | Acquired | (price as of 2026-10-02) |
| March 25, 2021 | XRAY | A | 2,320 | $52.36 | $121,475 | 5,224 Direct | +79.89% | Acquired | -83.4% (price as of 2026-10-02) |
| March 12, 2021 | XRAY | F | 716 | $62.88 | $45,022 | 46,445 Direct | -1.52% | Disposed | -86.2% (price as of 2026-10-02) |
| March 6, 2021 | XRAY | F | 417 | $60.00 | $25,020 | 47,161 Direct | -0.88% | Disposed | -85.6% (price as of 2026-10-02) |
| March 6, 2021 | XRAY | A | 1,448 | · | · | 47,578 Direct | +3.14% | Acquired | (price as of 2026-10-02) |
| March 6, 2021 | XRAY | F | 632 | $60.00 | $37,920 | 46,130 Direct | -1.35% | Disposed | -85.6% (price as of 2026-10-02) |
| March 4, 2021 | XRAY | A | 23,600 | · | · | 23,600 Direct | · | Acquired | (price as of 2026-10-02) |
| March 4, 2021 | XRAY | A | 6,387 | · | · | 46,762 Direct | +15.82% | Acquired | (price as of 2026-10-02) |
| March 4, 2021 | XRAY | F | 756 | $58.71 | $44,385 | 40,375 Direct | -1.84% | Disposed | -85.2% (price as of 2026-10-02) |
| Jan. 8, 2021 | XRAY | A | 5 | $58.84 | $294 | 2,904 Direct | +0.17% | Acquired | -85.3% (price as of 2026-10-02) |
| Jan. 8, 2021 | XRAY | A | 29 | · | · | 41,131 Direct | +0.07% | Acquired | (price as of 2026-10-02) |
| Oct. 9, 2020 | XRAY | A | 6 | $46.01 | $276 | 2,899 Direct | +0.21% | Acquired | -81.2% (price as of 2026-10-02) |
| Oct. 9, 2020 | XRAY | F | 8,400 | $45.50 | $382,200 | 41,103 Direct | -16.97% | Disposed | -80.9% (price as of 2026-10-02) |
| Oct. 9, 2020 | XRAY | A | 76 | · | · | 49,503 Direct | +0.15% | Acquired | (price as of 2026-10-02) |
| July 10, 2020 | XRAY | A | 7 | $41.55 | $291 | 2,893 Direct | +0.24% | Acquired | -79.1% (price as of 2026-10-02) |
| July 10, 2020 | XRAY | A | 76 | · | · | 49,427 Direct | +0.15% | Acquired | (price as of 2026-10-02) |
| May 19, 2020 | XRAY | F | 7,018 | $41.08 | $288,299 | 49,350 Direct | -12.45% | Disposed | -78.9% (price as of 2026-10-02) |
| May 19, 2020 | XRAY | A | 18,562 | · | · | 56,368 Direct | +49.10% | Acquired | (price as of 2026-10-02) |
| April 10, 2020 | XRAY | A | 7 | $40.26 | $282 | 2,886 Direct | +0.24% | Acquired | -78.5% (price as of 2026-10-02) |
| April 10, 2020 | XRAY | A | 86 | · | · | 37,806 Direct | +0.23% | Acquired | (price as of 2026-10-02) |
| March 19, 2020 | XRAY | A | 1,084 | $56.59 | $61,344 | 2,879 Direct | +60.39% | Acquired | -84.7% (price as of 2026-10-02) |
| March 12, 2020 | XRAY | F | 710 | $39.93 | $28,350 | 37,720 Direct | -1.85% | Disposed | -78.3% (price as of 2026-10-02) |
| March 6, 2020 | XRAY | F | 623 | $44.73 | $27,867 | 38,430 Direct | -1.60% | Disposed | -80.6% (price as of 2026-10-02) |
| March 4, 2020 | XRAY | A | 36,300 | · | · | 36,300 Direct | · | Acquired | (price as of 2026-10-02) |
| March 4, 2020 | XRAY | A | 7,577 | · | · | 39,053 Direct | +24.07% | Acquired | (price as of 2026-10-02) |
| Jan. 10, 2020 | XRAY | A | 3 | $57.82 | $173 | 1,794 Direct | +0.17% | Acquired | -85.0% (price as of 2026-10-02) |
| Jan. 10, 2020 | XRAY | A | 52 | · | · | 31,476 Direct | +0.17% | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2019 | XRAY | A | 3 | · | · | 1,791 Direct | +0.17% | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2019 | XRAY | A | 56 | · | · | 31,423 Direct | +0.18% | Acquired | (price as of 2026-10-02) |
| July 12, 2019 | XRAY | A | 3 | $56.82 | $170 | 1,788 Direct | +0.17% | Acquired | -84.7% (price as of 2026-10-02) |
| July 12, 2019 | XRAY | A | 45 | · | · | 31,367 Direct | +0.14% | Acquired | (price as of 2026-10-02) |
| April 12, 2019 | XRAY | A | 3 | $50.95 | $153 | 1,785 Direct | +0.17% | Acquired | -83.0% (price as of 2026-10-02) |
| April 12, 2019 | XRAY | A | 117 | · | · | 31,323 Direct | +0.37% | Acquired | (price as of 2026-10-02) |
| March 29, 2019 | XRAY | A | 1,782 | $37.21 | $66,308 | 1,782 Direct | · | Acquired | -76.7% (price as of 2026-10-02) |
| March 12, 2019 | XRAY | A | 30,600 | · | · | 30,600 Direct | · | Acquired | (price as of 2026-10-02) |
| March 12, 2019 | XRAY | A | 7,354 | · | · | 31,205 Direct | +30.83% | Acquired | (price as of 2026-10-02) |
| March 6, 2019 | XRAY | F | 612 | $47.75 | $29,223 | 23,851 Direct | -2.50% | Disposed | -81.8% (price as of 2026-10-02) |
| Jan. 11, 2019 | XRAY | A | 58 | · | · | 24,463 Direct | +0.24% | Acquired | (price as of 2026-10-02) |
| Oct. 12, 2018 | XRAY | A | 56 | · | · | 24,406 Direct | +0.23% | Acquired | (price as of 2026-10-02) |
| July 13, 2018 | XRAY | A | 49 | · | · | 24,349 Direct | +0.20% | Acquired | (price as of 2026-10-02) |
| April 13, 2018 | XRAY | A | 42 | · | · | 24,301 Direct | +0.17% | Acquired | (price as of 2026-10-02) |
| March 6, 2018 | XRAY | A | 29,600 | · | · | 29,600 Direct | · | Acquired | (price as of 2026-10-02) |
| March 6, 2018 | XRAY | A | 6,431 | · | · | 24,259 Direct | +36.07% | Acquired | (price as of 2026-10-02) |
| Jan. 12, 2018 | XRAY | A | 24 | · | · | 17,828 Direct | +0.13% | Acquired | (price as of 2026-10-02) |
| Oct. 10, 2017 | XRAY | A | 38,100 | $57.57 | $2,193,417 | 38,100 Direct | · | Acquired | -84.9% (price as of 2026-10-02) |
| Oct. 10, 2017 | XRAY | A | 17,804 | · | · | 17,804 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 8, 2021 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 10 | Acquired |
| July 9, 2021 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 9 | Acquired |
| April 9, 2021 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 8 | Acquired |
| March 25, 2021 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 2,320 | Acquired |
| March 4, 2021 | XRAY | Stock Option (Right to Buy) | Common Stock | $58.71 | March 4, 2031 | 23,600 | Acquired |
| Jan. 8, 2021 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 5 | Acquired |
| Oct. 9, 2020 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 6 | Acquired |
| July 10, 2020 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 7 | Acquired |
| April 10, 2020 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 7 | Acquired |
| March 19, 2020 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 1,084 | Acquired |
| March 4, 2020 | XRAY | Stock Option (Right to Buy) | Common Stock | $47.84 | March 4, 2030 | 36,300 | Acquired |
| Jan. 10, 2020 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 3 | Acquired |
| Oct. 11, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 3 | Acquired |
| July 12, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 3 | Acquired |
| April 12, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 3 | Acquired |
| March 29, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 1,782 | Acquired |
| March 12, 2019 | XRAY | Stock Option (Right to Buy) | Common Stock | $49.29 | March 12, 2022 | 30,600 | Acquired |
| March 6, 2018 | XRAY | Stock Option (Right to Buy) | Common Stock | $56.37 | March 6, 2028 | 29,600 | Acquired |
| Oct. 10, 2017 | XRAY | Stock Option (Right to Buy) | Common Stock | $57.57 | Oct. 10, 2020 | 38,100 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $134,795 | · | · | · | $41,100 | · | · | $1,733,673 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.